Ticker Symbol: ICPT
Intercept Pharmaceuticals Inc
$18.05 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001270073
Company Profile
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.interceptpharma.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $18.63
Change:
$0.03
(
0.16%)
Days Range: $18.55 - $18.63
Beta: -
52wk. High: $21.86
52wk. Low: $8.82
Ytd. Change 50.52%
50 Day Moving Average: $15.30
200 Day Moving Average: $13.25
Shares Outstanding: 41782727
Valuation
Market Cap: 77.8B
PE Ratio: 3.56
EPS (TTM): 5.24
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A